Lymphoma Therapy
Reports outline lymphoma therapy research from University of Rochester, James P. Wilmot Cancer Center
Published in Medical Device Law Weekly, March 4th, 2007
Fresh data on lymphoma are presented in the report "B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny." According to recent research from the United States, "The long-term immunologic effects of B cell depletion with rituximab and the characteristics of the reconstituting B cell pool in lymphoma patients are not well defined, despite the widespread usage of this therapy."
"Here we report that during the B cell reconstitution phase a majority of the peripheral blood B cells have an immature transitional phenotype (47.8%±25.2% vs. 4.4%±2.4% for normal controls, p<0.0001), similar to what has been described during...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Collaborations
Agreement signed between Ipsen and MSD to comarket Adrovance - Finance
Celera Group reports loss of $0.01 per share - Finance
Cooper Companies sets pricing of $350 million senior notes due 2015 - Legal Issues
Third Wave and Stratagene reach out-of-court settlement in patent litigation - Licensing Agreements
Critical Therapeutics licenses rights for vagus nerve stimulation device to Innovative Metabolics - Acute Lymphoblastic Leukemia Prognosis
Reports outline acute lymphoblastic leukemia prognosis study findings from University of Malaya, Department of Paediatrics - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
